"By it's very nature issuing of shares at a premium is accretive, issuing at a discount is dilutive."
If your definition of "accretive" relates to the last-traded share price then, yes, issuing stock at a higher price than the last traded price, is ...uh... accretive.
But if your definition of "accretive" relates to the fundamental valuation of the business, then issuing stock at a lower price is - axiomatically - not value accretive.
And, with little doubt, from a shareholder value standpoint, the reference price that matters is the fundamental valuation of the business, and not the market's arbitrary value of it.
But don't just take my word for it; any valuation theory textbook will say the same thing.
- Forums
- ASX - By Stock
- MSB
- Ann: MSB Enters Into Cardiovascular Alliance For China With Tasly
Ann: MSB Enters Into Cardiovascular Alliance For China With Tasly, page-120
-
- There are more pages in this discussion • 173 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
|
|||||
Last
97.0¢ |
Change
-0.005(0.51%) |
Mkt cap ! $1.107B |
Open | High | Low | Value | Volume |
98.5¢ | 98.5¢ | 96.0¢ | $2.168M | 2.226M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 16000 | 96.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.0¢ | 86854 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 16000 | 0.965 |
1 | 23000 | 0.960 |
4 | 56273 | 0.955 |
5 | 46225 | 0.950 |
2 | 65500 | 0.945 |
Price($) | Vol. | No. |
---|---|---|
0.970 | 50000 | 2 |
0.975 | 20000 | 1 |
0.980 | 894 | 1 |
0.985 | 48122 | 2 |
0.990 | 54328 | 5 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
MSB (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online